{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pennington",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA202332"
        ],
        "brand_name": [
          "OXYBUTYNIN"
        ],
        "generic_name": [
          "OXYBUTYNIN"
        ],
        "manufacturer_name": [
          "Zydus Pharmaceuticals USA Inc."
        ],
        "product_ndc": [
          "68382-255",
          "68382-256",
          "68382-257"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "OXYBUTYNIN CHLORIDE"
        ],
        "rxcui": [
          "863619",
          "863628",
          "863636"
        ],
        "spl_id": [
          "f54e4d4e-91be-4e10-a446-57ed5e1843a1"
        ],
        "spl_set_id": [
          "c042bf06-79a3-4dc7-ae05-3ef3cfae9d44"
        ],
        "package_ndc": [
          "68382-255-06",
          "68382-255-14",
          "68382-255-16",
          "68382-255-01",
          "68382-255-05",
          "68382-255-30",
          "68382-255-77",
          "68382-256-14",
          "68382-256-01",
          "68382-256-16",
          "68382-256-05",
          "68382-256-30",
          "68382-256-77",
          "68382-256-06",
          "68382-257-14",
          "68382-257-01",
          "68382-257-16",
          "68382-257-05",
          "68382-257-30",
          "68382-257-77",
          "68382-257-06"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "L9F3D9RENQ"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93100",
      "recalling_firm": "Zydus Pharmaceuticals (USA) Inc",
      "address_1": "73 Route 31 N",
      "address_2": "N/A",
      "postal_code": "08534-3601",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0038-2024",
      "product_description": "Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-256-05) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534",
      "product_quantity": "7,248 bottles",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20230921",
      "center_classification_date": "20231004",
      "termination_date": "20250806",
      "report_date": "20231011",
      "code_info": "Lot#: M300652 and M300651, exp. Dec 2024"
    }
  ]
}